home / stock / bcrx / bcrx news


BCRX News and Press, BioCryst Pharmaceuticals Inc.

Stock Information

Company Name: BioCryst Pharmaceuticals Inc.
Stock Symbol: BCRX
Market: NASDAQ
Website: biocryst.com

Menu

BCRX BCRX Quote BCRX Short BCRX News BCRX Articles BCRX Message Board
Get BCRX Alerts

News, Short Squeeze, Breakout and More Instantly...

BCRX - ORLADEYO® (berotralstat) Approved in Peru

RESEARCH TRIANGLE PARK, N.C., July 09, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the General Directorate of Medicines, Supplies and Drugs (DIGEMID) in Peru has granted approval for oral, once-daily ORLADEYO ® (berotralstat) for t...

BCRX - Trading (BCRX) With Integrated Risk Controls

2024-06-27 04:12:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

BCRX - Small-cap, buy-rated stocks with positive estimate revision factors - BofA

2024-06-25 14:07:48 ET More on iShares Russell 2000 ETF: IWM: Small Caps Look Unattractive With Deteriorating Earnings Outlook IWM: Favor Small Caps Over The Technology Sector IWM: Not The Economy For Underdogs (Rating Downgrade) Gap between growth and small-...

BCRX - Tracking Baker Brothers Portfolio - Q1 2024 Update

2024-06-11 00:24:03 ET Summary Baker Brothers' 13F portfolio value decreased from $8.79B to $7.97B. The largest five stakes in the portfolio are Incyte, BeiGene, ACADIA Pharma, Madrigal Pharma, and Rhythm Pharma. Baker Brothers has had successful investments in companies that ...

BCRX - (BCRX) Technical Data

2024-06-07 10:20:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

BCRX - BioCryst Presents New Real-world Evidence Showing Reductions in Attack Rates in HAE Patients with Normal C1-Inhibitor after Beginning ORLADEYO® (berotralstat) Treatment

RESEARCH TRIANGLE PARK, N.C., June 02, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced new real-world evidence showing that patients with hereditary angioedema (HAE) who have normal C1-inhibitor (HAE-nC1-INH) level and function had a reduction in mo...

BCRX - (BCRX) Investment Report

2024-05-17 02:20:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

BCRX - BioCryst spikes after a series of insider purchases

2024-05-15 10:12:07 ET More on BioCryst Pharmaceuticals BioCryst: Estimate-Beating Q1 But Risks Are Considerable BioCryst Pharmaceuticals, Inc. (BCRX) Q1 2024 Earnings Call Transcript BioCryst Pharmaceuticals, Inc. 2024 Q1 - Results - Earnings Call Presentation ...

BCRX - Biocryst Pharmaceuticals, T2 Biosystems, Annovis Bio among healthcare movers

2024-05-15 10:01:12 ET More on Health Care Select Sector SPDR XLV: Pivotal Week Of Earnings For Healthcare Stocks XLV: Fundamentals Don't Support Overweighting Health Care Health care is still very crowded but trades at a discount vs. history - BofA Health ca...

BCRX - OPEN, BCRX and AWIN among pre-market gainers

2024-05-15 09:25:53 ET Gainers: SINTX Technologies ( SINT ) +186% . Faraday Future Intelligent Electric ( FFIE ) +82% . Edible Garden AG EDBL +82% after Q1 earnings release . AERWINS Technologies ( AWIN ) +33% . Greenwave Technology Solu...

Next 10